Costco (NASDAQ:COST) shares held steady as the novel coronavirus pushed the stock market lower. That's no surprise, given the wave of panic buying as the pandemic hit America. But, while competitors like Walmart (NYSE:WMT) have made new highs, Costco stock has pulled back.Source: ilzesgimene / Shutterstock.com To me, that's a sign Costco shares are a buying opportunity on the dip. Why? The company's membership-based model gives it less volatile revenue. Granted, the company isn't the only player in the club retailer space. Not only do you have publicly traded BJ's Wholesale Club (NYSE:BJ), you also have Walmart's Sam's Club unit.Yet, Costco is leaps and bounds ahead of these rivals. Not just in size, but also in growth potential. The company's stores have continued to grow, while its peers tread water at best. In fact, places like Sam's Club have closed stores, while Costco continues to expand its reach.InvestorPlace - Stock Market...
Year-to-date, JPMorgan Chase (NYSE:JPM) stock is down about 33%. The Street is now debating whether the current global health crisis will also translate into a full-blown economic meltdown. So many investors were glad to say good riddance to the first quarter of the year. Now they are getting ready to embrace the potential volatility the upcoming earnings season is likely to bring to the JPM stock price.Today I'd like to discuss what the new quarter may mean for the shares of the banking giant which is expected to report first-quarter earnings on April 14.Variables such as interest rates, economic growth, global political developments and now pandemic worries all have an impact on a bank's stock price. Therefore there will likely be wide daily price swings in JPM shares as news headlines change. Long-term investors may consider buying the dips, especially if the price goes toward or below $80.InvestorPlace - Stock Market...
Amazon CEO Jeff Bezos made a surprise appearance at an Amazon fulfillment center and Whole Foods store on Wednesday. This comes after some warehouse employees in NYC held a walkout demanding more safety precautions amid the coronavirus. Yahoo Finance’s Sibile Marcellus joins Seana Smith to discuss....
Inovio Pharmaceuticals (NASDAQ:INO) has been in the spotlight recently after the company announced a potential vaccine for the novel coronavirus.Source: Ascannio / Shutterstock.com INO stock jumped more than 70% in the space of a week as investors saw promise in the Pennsylvania pharmaceutical firm. Since then, the firm's share price has come down substantially but remains 50% higher than it was trading just a few months ago.While the rest of the market is brimming with bargain buys, Inovio and a handful of others are currently trading at a premium due to thee potential windfall that a COVID-19 treatment would provide. But is the stock worth the hype? Here's a look at the case for INO stock. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Invio's Coronavirus VaccineThe past week has taken INO stock 12% higher as the firm moves forward with clinical trials for its coronavirus vaccine. The Food...
Investors are “way too enthralled” with trying to figure out what the shape of a recovery will look like, says one BMO strategist. “Stop trying to figure out whether or not it’s an ‘L’ or ‘V,’ and just let the market and the companies come back and get back to business,” Brian Belski, chief investment strategist at BMO Capital told Yahoo Finance....
